Bone tissue engineering with novel rhBMP2-PLLA composite scaffolds

Po Chun Chang, Bu Yuan Liu, Cheng Meei Liu, Hsin Hua Chou, Ming Hua Ho, Hwa Chang Liu, Da Ming Wang, Lein Tuan Hou

Research output: Contribution to journalArticle

45 Citations (Scopus)

Abstract

The aims of the present study were to fabricate a novel porous polylactic acid (PLLA) composite scaffold and evaluate the capacity of the scaffold in carrying recombinant bone morphogenetic protein 2 (rhBMP2) for engineering bone formation. The structures of the PLLA scaffolds were evaluated by SEM and the controlled release of rhBMP2 from the composite scaffolds was assayed by ELISA. Bone induction by the scaffolds loaded with or without rhBMP2 was performed in the calf muscle of twenty Wistar rats for 3, 7, 10, 14, and 28 days. Tissue specimens were examined by Masson's trichrome and von Kossa stainings, and immunohistochemistry of bone proteins. Our results indicated that a moderate foreign body reaction was found in control scaffolds, which lasted for 4 weeks. The addition of rhBMP2 to this novel scaffold dramatically alleviated the adverse responses to PLLA. Enhanced deposition of collagen matrix and endochondral formation were observed in rhBMP2-PLLA scaffolds at 7-10 days, compatible with an early release of rhBMP2 in the composite scaffolds. Bone sialoprotein and osteopontin were demonstrated simultaneously. Von Kossa staining was observed in the test group at 10-14 days. In conclusion, the PLLA scaffolds exhibited the capability of carrying rhBMP2 for inducing bone formation within 2 weeks. These results suggest that rhBMP2-PLLA scaffold may be applicable in tissue engineering.

Original languageEnglish
Pages (from-to)771-780
Number of pages10
JournalJournal of Biomedical Materials Research - Part A
Volume81
Issue number4
DOIs
Publication statusPublished - Jun 15 2007

Fingerprint

Scaffolds (biology)
Tissue engineering
Scaffolds
Bone
Acids
Composite materials
Proteins
poly(lactic acid)
Integrin-Binding Sialoprotein
Bone Morphogenetic Protein 2
Osteopontin
Collagen
Muscle
Rats
Tissue
Scanning electron microscopy

Keywords

  • Bone induction
  • Mineralization
  • Poly (L-lactic acid) polymer
  • Recombinant bone morphogenetic protein
  • Tissue engineering

ASJC Scopus subject areas

  • Biomedical Engineering
  • Biomaterials

Cite this

Bone tissue engineering with novel rhBMP2-PLLA composite scaffolds. / Chang, Po Chun; Liu, Bu Yuan; Liu, Cheng Meei; Chou, Hsin Hua; Ho, Ming Hua; Liu, Hwa Chang; Wang, Da Ming; Hou, Lein Tuan.

In: Journal of Biomedical Materials Research - Part A, Vol. 81, No. 4, 15.06.2007, p. 771-780.

Research output: Contribution to journalArticle

Chang, Po Chun ; Liu, Bu Yuan ; Liu, Cheng Meei ; Chou, Hsin Hua ; Ho, Ming Hua ; Liu, Hwa Chang ; Wang, Da Ming ; Hou, Lein Tuan. / Bone tissue engineering with novel rhBMP2-PLLA composite scaffolds. In: Journal of Biomedical Materials Research - Part A. 2007 ; Vol. 81, No. 4. pp. 771-780.
@article{4fdda57297a34045a0e58bb2c0fd4d36,
title = "Bone tissue engineering with novel rhBMP2-PLLA composite scaffolds",
abstract = "The aims of the present study were to fabricate a novel porous polylactic acid (PLLA) composite scaffold and evaluate the capacity of the scaffold in carrying recombinant bone morphogenetic protein 2 (rhBMP2) for engineering bone formation. The structures of the PLLA scaffolds were evaluated by SEM and the controlled release of rhBMP2 from the composite scaffolds was assayed by ELISA. Bone induction by the scaffolds loaded with or without rhBMP2 was performed in the calf muscle of twenty Wistar rats for 3, 7, 10, 14, and 28 days. Tissue specimens were examined by Masson's trichrome and von Kossa stainings, and immunohistochemistry of bone proteins. Our results indicated that a moderate foreign body reaction was found in control scaffolds, which lasted for 4 weeks. The addition of rhBMP2 to this novel scaffold dramatically alleviated the adverse responses to PLLA. Enhanced deposition of collagen matrix and endochondral formation were observed in rhBMP2-PLLA scaffolds at 7-10 days, compatible with an early release of rhBMP2 in the composite scaffolds. Bone sialoprotein and osteopontin were demonstrated simultaneously. Von Kossa staining was observed in the test group at 10-14 days. In conclusion, the PLLA scaffolds exhibited the capability of carrying rhBMP2 for inducing bone formation within 2 weeks. These results suggest that rhBMP2-PLLA scaffold may be applicable in tissue engineering.",
keywords = "Bone induction, Mineralization, Poly (L-lactic acid) polymer, Recombinant bone morphogenetic protein, Tissue engineering",
author = "Chang, {Po Chun} and Liu, {Bu Yuan} and Liu, {Cheng Meei} and Chou, {Hsin Hua} and Ho, {Ming Hua} and Liu, {Hwa Chang} and Wang, {Da Ming} and Hou, {Lein Tuan}",
year = "2007",
month = "6",
day = "15",
doi = "10.1002/jbm.a.31031",
language = "English",
volume = "81",
pages = "771--780",
journal = "Journal of Biomedical Materials Research - Part B Applied Biomaterials",
issn = "1552-4973",
publisher = "John Wiley and Sons Inc.",
number = "4",

}

TY - JOUR

T1 - Bone tissue engineering with novel rhBMP2-PLLA composite scaffolds

AU - Chang, Po Chun

AU - Liu, Bu Yuan

AU - Liu, Cheng Meei

AU - Chou, Hsin Hua

AU - Ho, Ming Hua

AU - Liu, Hwa Chang

AU - Wang, Da Ming

AU - Hou, Lein Tuan

PY - 2007/6/15

Y1 - 2007/6/15

N2 - The aims of the present study were to fabricate a novel porous polylactic acid (PLLA) composite scaffold and evaluate the capacity of the scaffold in carrying recombinant bone morphogenetic protein 2 (rhBMP2) for engineering bone formation. The structures of the PLLA scaffolds were evaluated by SEM and the controlled release of rhBMP2 from the composite scaffolds was assayed by ELISA. Bone induction by the scaffolds loaded with or without rhBMP2 was performed in the calf muscle of twenty Wistar rats for 3, 7, 10, 14, and 28 days. Tissue specimens were examined by Masson's trichrome and von Kossa stainings, and immunohistochemistry of bone proteins. Our results indicated that a moderate foreign body reaction was found in control scaffolds, which lasted for 4 weeks. The addition of rhBMP2 to this novel scaffold dramatically alleviated the adverse responses to PLLA. Enhanced deposition of collagen matrix and endochondral formation were observed in rhBMP2-PLLA scaffolds at 7-10 days, compatible with an early release of rhBMP2 in the composite scaffolds. Bone sialoprotein and osteopontin were demonstrated simultaneously. Von Kossa staining was observed in the test group at 10-14 days. In conclusion, the PLLA scaffolds exhibited the capability of carrying rhBMP2 for inducing bone formation within 2 weeks. These results suggest that rhBMP2-PLLA scaffold may be applicable in tissue engineering.

AB - The aims of the present study were to fabricate a novel porous polylactic acid (PLLA) composite scaffold and evaluate the capacity of the scaffold in carrying recombinant bone morphogenetic protein 2 (rhBMP2) for engineering bone formation. The structures of the PLLA scaffolds were evaluated by SEM and the controlled release of rhBMP2 from the composite scaffolds was assayed by ELISA. Bone induction by the scaffolds loaded with or without rhBMP2 was performed in the calf muscle of twenty Wistar rats for 3, 7, 10, 14, and 28 days. Tissue specimens were examined by Masson's trichrome and von Kossa stainings, and immunohistochemistry of bone proteins. Our results indicated that a moderate foreign body reaction was found in control scaffolds, which lasted for 4 weeks. The addition of rhBMP2 to this novel scaffold dramatically alleviated the adverse responses to PLLA. Enhanced deposition of collagen matrix and endochondral formation were observed in rhBMP2-PLLA scaffolds at 7-10 days, compatible with an early release of rhBMP2 in the composite scaffolds. Bone sialoprotein and osteopontin were demonstrated simultaneously. Von Kossa staining was observed in the test group at 10-14 days. In conclusion, the PLLA scaffolds exhibited the capability of carrying rhBMP2 for inducing bone formation within 2 weeks. These results suggest that rhBMP2-PLLA scaffold may be applicable in tissue engineering.

KW - Bone induction

KW - Mineralization

KW - Poly (L-lactic acid) polymer

KW - Recombinant bone morphogenetic protein

KW - Tissue engineering

UR - http://www.scopus.com/inward/record.url?scp=34249653007&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34249653007&partnerID=8YFLogxK

U2 - 10.1002/jbm.a.31031

DO - 10.1002/jbm.a.31031

M3 - Article

C2 - 17226806

AN - SCOPUS:34249653007

VL - 81

SP - 771

EP - 780

JO - Journal of Biomedical Materials Research - Part B Applied Biomaterials

JF - Journal of Biomedical Materials Research - Part B Applied Biomaterials

SN - 1552-4973

IS - 4

ER -